Our Leadership Team
Patrick Frankham, PHD
CEO & Director
Dr. Patrick Frankham founded several healthcare startup enterprises including healthcare information technology, services and pharmaceuticals companies. Dr. Frankham has over 20 years of experience in the biopharmaceutical and services industries across several therapeutic areas. His professional experience includes public and private companies as well as multinational corporations. Notable prior organizations where he held increasing leadership roles in Preclinical, Regulatory, Medical and Business Development include Phoenix International Life Sciences (MDS Pharma Services), AeternaZentaris, BioAxone Biosciences, ICON Clinical Research & Boehringer Ingelheim GmbH. While at Boehringer Ingelheim, he developed novel business models to optimize therapeutics by combining mobile technology and therapies. He is currently Vice President International, Physicians Interactive. Dr Frankham obtained his PhD in Molecular Endocrinology, Université Laval, Québec, Canada and his MBA in Management & Finance, University of Liverpool, UK.
Dr. Joseph Borovsky, PHD
Lead Director & Executive Vice President, Product Development
Dr. Borovsky is an experienced CEO and entrepreneur with broad-based success in leading major corporate research and development as well as innovative technology startups, P & L operations, sales, and marketing. Formerly the director of R & D for Mead Corporation, Dr. Borovsky received his Bachelor of Science degree in Chemistry from the University of California at Los Angeles, and his Ph.D. in Physical Organic Chemistry from the University of Massachusetts at Amherst. He also completed a year of post- doctoral research in Medicinal Chemistry at Washington State University College of Pharmacy, Pullman, WA, and was a Research Fellow in Synthetic Organic Chemistry at Harvard University in Cambridge, Massachusetts.
Wolfgang Renz, MD, PHD
Chief Medical Officer & Director
Wolfgang Renz is President of International Business at Physicians Interactive. Formerly, he served as Corporate Vice President of Business Model & Healthcare Innovation at Boehringer Ingelheim, one of the world’s largest pharmaceutical companies. For over a decade, he has been involved in developing medicines and technology to help people lead healthier, more productive lives. At Boehringer Ingelheim, he led a team of specialists to find, test, and develop the disruptive technologies that will shape the way health care will be delivered in the future. In addition, he also serves as Adjunct Professor of Surgery at McGill University’s Faculty of Medicine in Montreal, Canada. Prof. Renz holds a medical degree and a PhD from Freiburg University and is board certified in Germany in emergency medicine.
Moira Ong, CPA, CA
Chief Financial Officer
Moira Ong is a Chartered Professional Accountant with over 16 years of experience in accounting and consulting. Moira was the Chief Financial Officer of Neurokine Pharmaceuticals Inc. and was an officer in the finance capacity of Merus Labs International Inc. from March 2010 through December 2012. In addition to holding her Chartered Professional Accountant (CPA, CA) designation, Moira is also a Chartered Financial Analyst (CFA).
Dr. Leonid Lurya, MD, PHD
Executive Director of Formulations
Dr. Lurya is the inventor of Thrudermic transdermal technology and has extensive experience in leadership of multiple pharmaceutical projects, from the concept stage to pre-clinical and clinical stages (Phase I – Phase IV). He received his MD from the Moscow Medical Institute No. 2, Russia and then completed his PhD in Biophysics, Chemical Physics Department at the Weizmann Institute of Science, Israel.